10 Apr 2019

Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

NaTHNaC receives reassurance that contingencies for continuous yellow fever vaccine supply to the UK are robust and sustainable in the event of a ‘no deal’ EU Exit Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

On behalf of Yellow Fever Vaccination Centres (YFVC) in England, Wales and Northern Ireland, NaTHNaC has been working closely with Sanofi Pasteur who manufacture, pack and supply yellow fever vaccine in France for the UK market. Sanofi Pasteur advises that their contingency plan for a ‘no deal’ EU Exit includes increasing yellow fever vaccine stock levels and securing alternative and robust supply lines into the UK.

Local stockpiling is unnecessary and YFVC should continue to order YF vaccine as usual.

Further updates will be provided when available.

Resources

Polio: Public Health Emergency of International Concern

An update on the polio Public Health Emergency of International Concern (PHEIC) Read more

Global wildfires

A wildfire is an unplanned fire in a natural area such as forest, grassland or prairie Read more

Ebola virus disease (EVD): Democratic Republic of Congo- update

New confirmed cases continue to be reported in North Kivu and Ituri Provinces Read more

Measles outbreaks in the pacific and new entry requirements for travellers

An outbreak of measles is currently affecting a number of islands in the Pacific- travellers should check for possible new entry requirements Read more

Professor Dilys Morgan MBE to Chair NaTHNaC

Chair of the National Travel Health Network and Centre Technical Advisory Group appointed Read more
Back to Top

VIEW FULL INDEX